Compare Peptides
Select any two compounds for a side-by-side comparison of mechanism, uses, risks, and FDA regulatory status.
Popular comparisons
Thymosin Alpha-1 + Thymalin Protocol
TA1/Thymalin Stack, Immune Peptide Protocol
A combination protocol pairing Thymosin Alpha-1 (a 28-amino acid thymic peptide) with Thymalin (a thymic extract) for comprehensive immune system modulation. Based on the work of Vladimir Khavinson, this stack targets both innate and adaptive immunity. Used in integrative medicine for immune optimization, post-illness recovery, and longevity protocols.
A thymic peptide bioregulator developed by Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology. Thymalin is a complex of polypeptides extracted from the thymus gland that has been used clinically in Russia since the 1980s for immune restoration. Khavinson's research group reported that thymalin treatment in elderly patients was associated with reduced mortality over a 6-year follow-up period.
Thymosin Alpha-1 activates dendritic cells, enhances T-cell maturation, and modulates Th1/Th2 balance. Thymalin provides a broader spectrum of thymic peptides that support thymic function and T-cell diversity. Together, they address both the specific (TA1) and general (Thymalin) aspects of thymic immune regulation.
Contains a mixture of thymic peptides that restore T-cell function and thymic output. Proposed to act through epigenetic mechanisms, reactivating genes involved in immune function that become silenced with aging. May promote thymic regeneration and restore the balance between T-helper and T-suppressor cells.
- Comprehensive immune optimization
- Post-viral recovery protocols
- Chronic infection support
- Longevity and immune aging (immunosenescence)
- Pre-travel immune preparation
- Immune system restoration in elderly patients
- Post-infection immune recovery
- Anti-aging and longevity protocols
- Adjunct to cancer immunotherapy (in Russian clinical practice)
- Injection site reactions from both peptides
- Potential for immune overstimulation
- Autoimmune flare risk in predisposed individuals
- Cost — both peptides required
- Limited data on combination safety
- Limited Western clinical data
- Most research from Russian institutions — peer review concerns
- Allergic reactions possible (animal-derived extract)
- Quality varies significantly between sources
Thymosin Alpha-1 is FDA-approved internationally (Zadaxin) but not in the US. Thymalin has no FDA status. The combination protocol is not FDA-reviewed. Both are available through compounding pharmacies. TA1 is on the 503A Category 1 bulks list.
Not FDA-approved or recognized. Used clinically in Russia and some CIS countries. No FDA category. Available only as a research peptide in the US. Khavinson's longevity claims, while published, have not been replicated in Western clinical trials.
This comparison is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any peptide therapy.